Literature DB >> 25466468

Imaging of acute stroke: CT and/or MRI.

Karl-Olof Lövblad1, Stephen Altrichter2, Vitor Mendes Pereira2, Maria Vargas2, Ana Marcos Gonzalez2, Sven Haller2, Roman Sztajzel2.   

Abstract

Acute ischemic stroke is now clearly recognized as a medical emergency. As such diagnosis has to be done quickly and in a precise way during the therapeutic window. Both computed tomography and magnetic resonance imaging are tools that can adequately demonstrate ischemia really very early on. MRI using diffusion techniques has a much higher sensitivity for acute lesions but its implementation has not been unproblematic due to initial resistance and some technical problems. Thus, very often CT is still preferred with MR used for situations where the answer given is not sufficient as well as for follow-up of lesions. However, the parallel development of new therapeutic strategies have rendered the precision of the tools more and more sophisticated and their combined use can help to improve patient outcomes in ways never imagined previously. No matter which technique is used, be it alone or in combination, the idea is to speed up and optimize management in order to provide early revascularization and reperfusion.
Copyright © 2014. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Computed tomography; Imaging; Magnetic resonance imaging; Stroke

Mesh:

Year:  2014        PMID: 25466468     DOI: 10.1016/j.neurad.2014.10.005

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  4 in total

Review 1.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Impact of acute-phase complications and interventions on 6-month survival after stroke. A prospective observational study.

Authors:  Antonio Di Carlo; Maria Lamassa; Marco Franceschini; Francesca Bovis; Lorenzo Cecconi; Sanaz Pournajaf; Stefano Paravati; Annibale Biggeri; Domenico Inzitari; Salvatore Ferro
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

3.  Multimodal 3D DenseNet for IDH Genotype Prediction in Gliomas.

Authors:  Sen Liang; Rongguo Zhang; Dayang Liang; Tianci Song; Tao Ai; Chen Xia; Liming Xia; Yan Wang
Journal:  Genes (Basel)       Date:  2018-07-30       Impact factor: 4.096

4.  Deep profiling of multiple ischemic lesions in a large, multi-center cohort: Frequency, spatial distribution, and associations to clinical characteristics.

Authors:  Anna K Bonkhoff; Teresa Ullberg; Martin Bretzner; Sungmin Hong; Markus D Schirmer; Robert W Regenhardt; Kathleen L Donahue; Marco J Nardin; Adrian V Dalca; Anne-Katrin Giese; Mark R Etherton; Brandon L Hancock; Steven J T Mocking; Elissa C McIntosh; John Attia; John W Cole; Amanda Donatti; Christoph J Griessenauer; Laura Heitsch; Lukas Holmegaard; Katarina Jood; Jordi Jimenez-Conde; Steven J Kittner; Robin Lemmens; Christopher R Levi; Caitrin W McDonough; James F Meschia; Chia-Ling Phuah; Stefan Ropele; Jonathan Rosand; Jaume Roquer; Tatjana Rundek; Ralph L Sacco; Reinhold Schmidt; Pankaj Sharma; Agnieszka Slowik; Alessandro Sousa; Tara M Stanne; Daniel Strbian; Turgut Tatlisumak; Vincent Thijs; Achala Vagal; Daniel Woo; Ramin Zand; Patrick F McArdle; Bradford B Worrall; Christina Jern; Arne G Lindgren; Jane Maguire; Ona Wu; Petrea Frid; Natalia S Rost; Johan Wasselius
Journal:  Front Neurosci       Date:  2022-08-25       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.